Picornavirus Genome Replication
小核糖核酸病毒基因组复制
基本信息
- 批准号:10640512
- 负责人:
- 金额:$ 4.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-20 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAchievementAddressAffectAmino Acid SubstitutionAnabolismAtomic Force MicroscopyBindingBinding ProteinsBinding SitesBiochemistryBiogenesisBiological AssayCell LineCellsCoat Protein Complex ICollaborationsComplexConsensusDevelopmentDockingExhibitsFamily PicornaviridaeFundingGBF1 geneGeneticGenomeGoalsGrantGuanine Nucleotide Exchange FactorsHumanHuman poliovirusImageInfectionIntegration Host FactorsInvestigationKnowledgeLaboratoriesLife Cycle StagesLipid BilayersLipidsMembraneMembrane ProteinsMicrofluidicsModelingMolecularMolecular and Cellular BiologyMorbidity - disease rateNMR SpectroscopyNonlyticNull LymphocytesOrganellesPathway interactionsPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositolsPhospholipidsPhosphotransferasesPicornaviridae InfectionsProcessProductionProteinsProteomicsPublic HealthRNA VirusesRoleSERPINA4 geneSite-Directed MutagenesisStructural ModelsStructureStructure-Activity RelationshipTertiary Protein StructureTestingTimeUncertaintyUniversitiesVaccinesViral ProteinsVirusVirus DiseasesWorkbaseinhibitorinsightinterestmolecular dynamicsmortalitynovelphosphatidylinositol 4-phosphaterecruitscaffoldthree-dimensional modeling
项目摘要
Project Abstract
This is an application for renewal of a grant to study picornavirus genome replication. Studies of poliovirus
(PV) continue to establish paradigms for the molecular and cellular biology of all positive-strand RNA viruses
capable of causing morbidity and/or mortality in humans. PV replicates its genome in association with
membranes. In fact, the virus creates its own genome-replication organelle (RO) with a unique lipid
composition, including an abundance of the phosphoinositide (PIP), phosphatidylinositol-4-phosphate (PI4P).
During the past five years, many laboratories have been in search of the mechanism by which PI4P
biosynthesis is induced by various picornaviruses, including PV. In general, these studies tested the
hypothesis that a single viral protein hijacks a single cellular PI4 kinase (PI4K), leading to kinase relocalization
and synthesis of PI4P. Because of the long-established connection between the enteroviral 3A(B) protein and
the guanine nucleotide exchange factor, GBF1, most of the early studies focused on 3A(B) and concluded that
this viral protein is responsible for hijacking a PI4K, often by an indirect mechanism. However, this once-held
consensus opinion has now returned to uncertainty. Many years ago, our laboratory obtained genetic
evidence of a possible role of 3CD in the biogenesis of PV RO. During the previous funding period, we made a
definitive connection between 3CD and RO biogenesis by showing that 3CD is both necessary and sufficient
for induction of PI4P biosynthesis in cells. We demonstrated that the normal cellular GBF1-Arf1-PI4K axis is
employed. We identified two derivatives of 3CD with amino acid substitutions in the 3C domain (3CmD) or 3D
domain (3CDm) that are defective for induction of PI4P biosynthesis at discrete steps in this pathway. In both
instances, the derivatives exhibit perturbations to PIP-binding activity of 3CD. In addition to PI4P, 3CD also
induces PI(4,5)P2 (PIP2) biosynthesis in cells. PIP2 induction does not arise from the 3CD-dependent
increase in PI4P but appears to be a distinct process based on the observation that both 3CmD and 3CDm
proteins remain competent for PIP2 induction. PV 3CD is a PIP-binding protein and a regulator of multiple PIP
biosynthetic pathways. Our proposed studies aim to address how and why. During the next funding period,
we will pursue the following specific aims: (1) Define the structure-function relationships of the PIP-binding
domains of 3C and 3D alone and in the context of 3CD; (2) Elucidate the mechanism of induction of PI4P
biosynthesis by 3CD alone and in the context of infection; and (3) Elucidate the mechanism of induction of
PIP2 biosynthesis by 3CD alone and in the context of infection.
项目摘要
这是一份续签研究小核糖核酸病毒基因组复制拨款的申请。脊髓灰质炎病毒的研究
(PV)继续建立所有正链RNA病毒的分子和细胞生物学范例
能够导致人类发病和/或死亡。 PV 复制其基因组与
膜。事实上,该病毒利用独特的脂质创建了自己的基因组复制细胞器(RO)
成分,包括丰富的磷酸肌醇 (PIP)、4-磷酸磷脂酰肌醇 (PI4P)。
在过去的五年里,许多实验室一直在寻找 PI4P 的作用机制。
生物合成由多种小核糖核酸病毒(包括PV)诱导。总的来说,这些研究测试了
假设单个病毒蛋白劫持单个细胞 PI4 激酶 (PI4K),导致激酶重新定位
以及PI4P的合成。由于肠道病毒 3A(B) 蛋白与
鸟嘌呤核苷酸交换因子 GBF1,大多数早期研究集中在 3A(B) 并得出结论:
这种病毒蛋白通常通过间接机制劫持 PI4K。然而,这个曾经举办过的
共识现在又回到了不确定性。很多年前,我们的实验室获得了遗传
3CD 在 PV RO 生物发生中可能发挥作用的证据。在上一个资助期间,我们做了一个
通过证明 3CD 是必要且充分的,得出 3CD 和 RO 生物发生之间的明确联系
用于诱导细胞内 PI4P 生物合成。我们证明正常细胞 GBF1-Arf1-PI4K 轴是
受雇。我们鉴定了 3C 结构域 (3CmD) 或 3D 中氨基酸取代的 3CD 的两种衍生物
结构域 (3CDm),该结构域在该途径的离散步骤中诱导 PI4P 生物合成有缺陷。在两者中
例如,衍生物对 3CD 的 PIP 结合活性表现出干扰。除了PI4P之外,还有3CD
诱导细胞内 PI(4,5)P2 (PIP2) 生物合成。 PIP2 诱导并非由 3CD 依赖性引起
PI4P 增加,但根据 3CmD 和 3CDm 的观察,这似乎是一个不同的过程
蛋白质仍然能够诱导 PIP2。 PV 3CD 是一种 PIP 结合蛋白,也是多种 PIP 的调节剂
生物合成途径。我们提出的研究旨在解决如何以及为何。在下一个资助期内,
我们将追求以下具体目标:(1)定义PIP结合的结构-功能关系
单独的 3C 和 3D 领域以及 3CD 背景下的领域; (2)阐明PI4P的诱导机制
单独通过 3CD 进行生物合成以及在感染情况下进行生物合成; (3) 阐明诱导机制
单独通过 3CD 以及在感染情况下进行 PIP2 生物合成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRAIG E. CAMERON其他文献
CRAIG E. CAMERON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRAIG E. CAMERON', 18)}}的其他基金
Optimizing nucleoside analog efficacy with novel exonuclease inhibitors
使用新型核酸外切酶抑制剂优化核苷类似物的功效
- 批准号:
10514274 - 财政年份:2022
- 资助金额:
$ 4.82万 - 项目类别:
Enteroviral 2C protein as a therapeutic target
肠道病毒2C蛋白作为治疗靶点
- 批准号:
10609524 - 财政年份:2022
- 资助金额:
$ 4.82万 - 项目类别:
Enteroviral 2C protein as a therapeutic target
肠道病毒2C蛋白作为治疗靶点
- 批准号:
10450381 - 财政年份:2022
- 资助金额:
$ 4.82万 - 项目类别:
Contribution of IL-32 gene expression to viral persistence
IL-32 基因表达对病毒持久性的贡献
- 批准号:
10177863 - 财政年份:2020
- 资助金额:
$ 4.82万 - 项目类别:
Contribution of IL-32 gene expression to viral persistence
IL-32 基因表达对病毒持久性的贡献
- 批准号:
10057016 - 财政年份:2020
- 资助金额:
$ 4.82万 - 项目类别:
相似国自然基金
共和盆地东北部地区隆升剥蚀过程对干热岩形成就位的影响:来自低温热年代学的制约
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
朱鹮野生种群营养生态位对繁殖成就的影响及保护对策研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
成就目标视角下建言韧性的形成机制与作用效果研究
- 批准号:72102228
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
科研人员流动与职业成就的关系研究
- 批准号:71874049
- 批准年份:2018
- 资助金额:48.0 万元
- 项目类别:面上项目
基于目标成就评量的社区中医药健康管理服务评价及优化策略研究
- 批准号:71874047
- 批准年份:2018
- 资助金额:49.0 万元
- 项目类别:面上项目
相似海外基金
Identifying human-specific neural progenitors and their role in neurodevelopment
识别人类特异性神经祖细胞及其在神经发育中的作用
- 批准号:
10662868 - 财政年份:2023
- 资助金额:
$ 4.82万 - 项目类别:
Identifying human-specific neural progenitors and their role in neurodevelopment
识别人类特异性神经祖细胞及其在神经发育中的作用
- 批准号:
10662868 - 财政年份:2023
- 资助金额:
$ 4.82万 - 项目类别:
Language Input as a Mechanism Underlying Socioeconomic Disparities in Neurocognitive Development
语言输入作为神经认知发展社会经济差异的机制
- 批准号:
10706839 - 财政年份:2023
- 资助金额:
$ 4.82万 - 项目类别: